|
MOSPD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.01700000004956E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.442800E-04 |
| Normal-vs-Stage2 |
2.269600E-01 |
| Normal-vs-Stage3 |
1.24810000001752E-07 |
| Normal-vs-Stage4 |
2.444000E-02 |
| Stage1-vs-Stage2 |
6.251200E-01 |
| Stage1-vs-Stage3 |
2.973800E-02 |
| Stage1-vs-Stage4 |
5.419400E-01 |
| Stage2-vs-Stage3 |
1.012650E-01 |
| Stage2-vs-Stage4 |
4.294400E-01 |
| Stage3-vs-Stage4 |
5.680400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.57329999994626E-06 |
| Normal-vs-AfricanAmerican |
2.891200E-01 |
| Normal-vs-Asian |
1.262400E-01 |
| Caucasian-vs-AfricanAmerican |
3.967600E-01 |
| Caucasian-vs-Asian |
8.437000E-01 |
| AfricanAmerican-vs-Asian |
7.468600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.3070000000347E-06 |
| Normal-vs-Female |
3.281900E-03 |
| Male-vs-Female |
6.004600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.343560E-01 |
| Normal-vs-Age(41-60Yrs) |
1.341930E-03 |
| Normal-vs-Age(61-80Yrs) |
1.79044999999434E-05 |
| Normal-vs-Age(81-100Yrs) |
1.409500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.977600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.753400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.394000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.838800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.863450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.756200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.333800E-01 |
| Normal-vs-Grade 2 |
9.778400E-04 |
| Normal-vs-Grade 3 |
7.53820000000127E-05 |
| Normal-vs-Grade 4 |
3.607100E-04 |
| Grade 1-vs-Grade 2 |
5.466400E-01 |
| Grade 1-vs-Grade 3 |
3.877200E-01 |
| Grade 1-vs-Grade 4 |
2.241800E-01 |
| Grade 2-vs-Grade 3 |
3.123400E-01 |
| Grade 2-vs-Grade 4 |
7.462300E-02 |
| Grade 3-vs-Grade 4 |
3.483200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.13829999998694E-07 |
| Normal-vs-ccB subtype |
6.676500E-03 |
| ccA subtype-vs-ccB subtype |
2.260600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.119200E-03 |
| Normal-vs-N1 |
2.08489999997674E-06 |
| N0-vs-N1 |
1.827900E-02 |
|
|
